Sun Genomics Launches CLIA Validated COVID-19 Detection Test


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Sun Genomics Launches CLIA Validated COVID-19 Detection Test
Sun Genomics, the direct-to-consumer custom probiotics, and gut health company announce the launch of its at-home Floré Labs COVID-19 Stool Test.

Sun Genomics, the direct-to-consumer custom probiotics, and gut health company announce the launch of its at-home Floré Labs COVID-19 Stool Test, available this week, to identify whether an individual has viral shedding of the SARS-CoV-2 Virus and therefore risk long hauler symptoms or potentially contagious.

New data, including that performed by Sun Genomics, show the Virus can be shed in the stool for up to 28 days. This indicates that once infected, even a negative Virus test result does not guarantee one is not contagious.

Sun Genomics’ COVID-19 Assay, designed and optimized by the company’s team of microbiologists, is performed using an RT-qPCR methodology approved by the Center for Disease Control. The analysis begins with an RNA extraction from one’s stool sample using an in-house CLIA approved technique. Within the results, there are identifiable markers that allow for COVID-19 detection.

“As we head into the holidays and people take extra precautions before seeing loved ones, it’s not only a question whether a person has tested negative for the Virus, but also to understand whether they may be a risk of COVID long hauler symptoms,” said Sunny Jain, founder, and CEO, Sun Genomics. “There have been significant advancements in the field of rapid testing of nasal passages and saliva, and they play an important role in flattening the curve and reducing the spread of the Virus. Our stool test for COVID-19 will play just as an important role for individuals who are looking to safely visit family, return to work or school, or reduce future side-effects.”

“While the stool testing process for COVID-19 differs from our traditional gut microbiome analysis, we feel uniquely well-positioned to develop and commercialize this cutting edge test,” said Philip Cotter, Ph.D., Regulatory, Commercialization, and Clinical Testing at Sun Genomics. “The CLIA lab certification was a critical step in making this test possible and we’re keen to see the possibilities this accreditation brings to future opportunities at Sun Genomics.”

The new test, which delivers results in three days, is available for purchase via Sun Genomics’ website for $129, or $79 when bundled with the Floré Gut Test.

About Sun Genomics
Sun Genomics is a first-of-its-kind, custom probiotics startup with the mission to improve gut health through personalized science. The company’s first consumer product, Floré, allows consumers to analyze the microflora of their stool and uses the results to craft a custom probiotic. Through DNA sequencing, Floré formulates the right probiotics for each customer’s specific needs and delivers it directly to their door. Sun Genomics has created the first feedback loop to allow customers to see their probiotics show up on their report, through a retest, and allows customers to improve their microflora over time.

Tags : #SunGenomics #healthcompany #at-homeFlorLabs #COVID-19StoolTest #SARS-CoV-2Virus #Covid-19 #Covid-19Virus #RT-qPCRmethodology #CenterforDiseaseControl #CLIAlab #FightAgainstVirus #Covid19Updates22Dec2020

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026